Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS) (HELP)

22 maggio 2026 aggiornato da: Donald Hayes Arnold, Vanderbilt University Medical Center
This is a clinical trial to determine the extent to which ultrasound-assisted lumbar puncture using a standardized procedure, including use of ultrasound to ascertain the presence of cerebrospinal fluid (CSF) at L3 - L5 and the optimal needle insertion distance, increases the acquisition rate of CSF that is interpretable for patient management.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Lumbar puncture (LP) is a frequently performed procedure in pediatric emergency departments, most often to evaluate meningitis in hyperthermic, hypothermic, or ill-appearing neonates, infants and children. Older children often present with headaches, meningismus, and/or altered mental status.

The risks of LP include introduction of pathogens, pain, the need for multiple attempts, and failure to obtain interpretable CSF. The latter frequently leads to a spine ultrasound study the following day and, if this does not demonstrate an epidural blood clot, repeat lumbar puncture using fluoroscopic guidance by interventional radiologists.

In evaluating the management of infant sepsis, one study found that the success of the initial LP plays a significant role: infants with unsuccessful initial LPs have longer hospital stays and require more resources. Therefore, ensuring successful LPs on the first attempt is critical for minimizing healthcare utilization, optimizing patient care, and decreasing the emotional burden of this procedure on parents and patients.

Unfortunately, epidural hematoma (EDH) is not uncommon after LP, with U/S diagnosed EDH identified among 40% of patients < 6 months with a traumatic LP and among 31% of unsuccessful but nontraumatic LP's, with complete effacement of the thecal sac in 17%. The spinal canal is wide enough to accommodate EDH with only rare sequelae. However, intramedullary hemorrhage of the conus medullaris resulting in paraplegia in a neonate has been reported.

Since the introduction of the revised febrile neonate guidelines in 2021,4 the number of lumbar punctures performed in young infants has decreased substantially. A consequence of performing fewer lumbar punctures is that clinicians-particularly trainees and early-career practitioners-have fewer opportunities to maintain procedural competence. As procedural skill and confidence decline, the risk of obtaining non-interpretable or traumatic samples increases.

Clearly, improvement of the traditional approach to LP in neonates and infants and young children is needed to prevent these complications. Ultrasound is an imaging modality that is frequently used in the emergency department and does not involve ionizing radiation. Ultrasound can be used prior to lumbar punctures to identify critical anatomical landmarks and needle-insertion distances to avoid the posterior epidural venous plexus and to increase the proportion of LP's with non-traumatic, interpretable CSF. However, an ultrasound technique that is easily learned and that can be applied accurately and efficiently in the emergency department is lacking. Incorporating ultrasound (U/S) into LP training or performance may help clinicians who perform the procedure infrequently to improve success rates and obtain interpretable cerebrospinal fluid samples through identifying optimal intervertebral spaces, visualizing spinal anatomy, and guiding needle placement.

This study employs a standardized, ultrasound-assisted LP approach that integrates pre-procedural identification of spinal anatomy and measurement of the optimal needle insertion distance along the angled trajectory to potentially minimize traumatic taps. Unlike traditional LP methods, this approach provides objective, reproducible guidance that can be given and applied by clinicians. The study is novel in its prospective assessment of ultrasound-guided LP outcomes. By evaluating interpretable CSF yield, this research advances pediatric procedural methodology and has the potential to establish a new standard of care for LP in young infants.

The overarching aim of this research is to determine whether U/S-assisted LP increases the rate of interpretable CSF from the current, approximately 65% to at least 80%.

Primary Aim: To determine the extent to which ultrasound-assisted lumbar puncture using a standardized procedure, including use of ultrasound to ascertain the presence of cerebrospinal fluid (CSF) at L3 - L5 and the optimal needle insertion distance, increases the acquisition rate of CSF that is interpretable for patient management.

Hypothesis: The standardized, ultrasound-assisted procedure for lumbar puncture in neonates and infants is associated with yield of interpretable CSF of at least 85%.

A Sufficient U/S study includes visualization of the following with each reported by the proceduralist on the data report form:

  1. Lower lumbar and S1 spinous processes visualized
  2. S1 drop-off
  3. L4-5 and/or L3-5 interspaces visualized
  4. Presence of CSF sufficient for LP
  5. Cauda Equina

Inclusion of lumbar punctures for which U/S was not performed:

We will review and record the results of studies performed without U/S guidance, the technique used by clinicians not participating in this study provide a prospectively acquired control group with which to compare outcomes after U/S measurement. This data will be used in the multivariable regression models described below.

Use of Previously Obtained Ultrasound Images:

As part of this study, investigators may utilize ultrasound images that were obtained as part of routine clinical care prior to the performance of lumbar puncture. These ultrasound images will have been acquired independently of, and prior to, study enrollment and will not require any additional imaging procedures for research purposes. When used for research analysis, ultrasound images will be limited to those relevant to the study objectives. Images will be accessed only by authorized study personnel and will be de-identified prior to analysis whenever feasible. No additional risk to participants is anticipated as a result of using these previously obtained clinical images.

Tipo di studio

Interventistico

Iscrizione (Stimato)

80

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Tennessee
      • Nashville, Tennessee, Stati Uniti, 37232

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • - Neonates and infants (< 12 months)
  • Hemodynamically stable
  • Undergoing a lumbar puncture for diagnostic testing

Exclusion Criteria:

  • - Infants > 12 months and 1 day
  • Signs of clinical instability
  • Known spinal anomalies (e.g., spina bifida, meningomyelocele) or previous spinal surgery

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Diagnostico
  • Assegnazione: Non randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Ultrasound
Intervention: Ultrasound of spinal canal
Ultrasound of spinal canal without contrast. We included the term "ultrasound contrast" because the choices were limited.
Nessun intervento: Control Group
Infants undergoing lumbar puncture without ultrasound assist

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Successful LP rate
Lasso di tempo: Time from lumbar puncture to results of CSF returned by lab, approximately 1 hour.
Acquisition of CSF sufficient for cell count, culture and meningoencephalitis PCR panel (MEP).
Time from lumbar puncture to results of CSF returned by lab, approximately 1 hour.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Unsuccessful ultrasound attempt
Lasso di tempo: Immediately after intervention
Ultrasound attempt in which the ultrasound operator could not complete the study and, as a result, did not attempt to use ultrasound images to inform LP. Potential causes include but are not limited to infant fussiness, inability to maintain positioning sufficient for ultrasound, and malfunction of the ultrasound machine.
Immediately after intervention
Traumatic LP rate
Lasso di tempo: Time from lumbar puncture to results of CSF returned by lab, approximately 1 hour
CSF RBC count > 500 cells/mm, the most widely accepted definition of traumatic LP. 10-12 The rate of traumatic LPs using this definition is 35 - 47% in neonates and 22 - 26% in infants (< 13 months).
Time from lumbar puncture to results of CSF returned by lab, approximately 1 hour
Number of attempts/ Number of Fluoroscopy-guided lumbar puncture (LP)
Lasso di tempo: Immediately after intervention
Number of attempts required for CSF acquisition or need for fluoroscopy-guided LP
Immediately after intervention

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

16 maggio 2026

Completamento primario (Stimato)

30 giugno 2027

Completamento dello studio (Stimato)

30 giugno 2028

Date di iscrizione allo studio

Primo inviato

18 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

22 maggio 2026

Primo Inserito (Effettivo)

29 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

29 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

22 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Descrizione del piano IPD

Will consider requests for data sharing individually and with a Data Use Agreement executed and approved by Vanderbilt University Medical Center.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

prodotto fabbricato ed esportato dagli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su ultrasound contrast

Sottoscrivi